Iindaba

Ngomhla wama-29 kuMatshi ngo-2022, iChunli, i-Weigao Orthopedics, i-Dabo kunye namanye amashishini ezixhobo zonyango ze-orthopedic akhuphe iingxelo zokusebenza zonyaka ze-2021. Phantsi kweempembelelo zezinto ezinjengokubuyiselwa kancinci kancinci komthamo wokusebenza kunye nokutshona kunye nokusasazwa kwamajelo okuthengisa, ingeniso yenkampani kunye nengeniso yemali iye yanda ukuya kuthi ga kwinqanaba elithile.

Ngo-2021, iShandong Weigao Orthopedic Device Co., Ltd izuze ingeniso yokusebenza ye-yuan eyi-2.154 yeebhiliyoni, ukukhula konyaka-ngonyaka nge-18.08%; Inzuzo eseleyo kubanini-zabelo kwiinkampani ezidwelisiweyo yi-690 yezigidi zeeyuan, inyuke nge-23.62% ngonyaka; Intsalela yemali evela kwimisebenzi yokusebenza ibizizigidi ezingama-788 zeeyuan, inyuke nge-22.38% ngonyaka, umvuzo osisiseko ngesabelo ngasinye yi-yuan eyi-1.82.

I-Beijing Chunlizhengda Medical Instruments Co., Ltd. kunye ne-Double Medical Technology Inc nayo yakhupha iingxelo zentsebenzo yonyaka ye-2021, kukho ukwanda kuzo zonke izikhombisi zabo zokusebenza eziphambili.
Ngokwengxelo efanelekileyo, ngo-2019, iinkampani ezintlanu eziphezulu kwimarike iyonke yezixhobo zonyango zokufakelwa kwamathambo e-China yayinguJohnson & Johnson, Medtronic, Zimmer kunye ne-Weigo.

Kwezinye iindaba, kutsha nje, iofisi ye-inshurensi yezempilo yesizwe, eTshayina. I-Ofisi Jikelele ye-NHC ikhuphe ngokudibeneyo iiNgcaciso malunga nokuThengwa okuPhakathi kunye nokuSetyenziswa kwezinto eziThengiswayo zoNyango ezikwixabiso eliphezulu (i-Artificial Joint) yimibutho yeSizwe (i-Ofisi ye-Inshurensi yezoNyango engunombolo 4, yowama-2022).
Kuyaqondwa ukuba iphondo lase-Anhui ngaphambili lenze imijikelo emibini yokuqokelela iimpahla zomnqonqo. NgoJulayi kulo nyaka uphelileyo, kumjikelo wesibini wemigodi enzulu yezinto ezityiwayo zomnqonqo e-Anhui, olona kuncipha luphezulu lwafikelela kuma-82.88%, ngokuncipha komyinge wama-54.6%.
I-Centralised Procurement iya kucinezela iingeniso zeenkampani ezidwelisiweyo, ukunciphisa iindleko zamashishini ukwenza uxinzelelo oluthile.